NCT07292207 2025-12-18
ARCHE
Nagoya City University
Phase 2 Not yet recruiting
Clinical Trials
15 trialsNCT04456920 2025-12-02
BIO-PSY
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT06033092 2025-08-28
TOLERANT
European Institute of Oncology
Phase 2 Active not recruiting
NCT04055493 2025-08-26
ADAPTcycle
West German Study Group
Phase 3 Active not recruiting
NCT06150898 2025-06-13
KePreSt
Jules Bordet Institute
Phase 2 Recruiting
NCT06774885 2025-01-14
ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS
Future University in Egypt
Phase 3 Not yet recruiting
NCT05163106 2024-08-02
NEOLETRIB
University Hospital, Akershus
Phase 2 Completed
NCT06229067 2024-01-29
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT05840068 2023-05-03
IGF Level in Breast Cancer Patients Treated With Metformin
Beni-Suef University
Phase 4 Completed
NCT02897050 2022-04-20
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Suspended
NCT04389073 2022-02-25
Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT04601116 2021-01-14
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Aarhus University Hospital
Phase 3 Recruiting
NCT04434404 2020-06-16
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
Phase 4 Completed
NCT03405168 2018-11-16
Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer
Sun Yat-sen University
Phase 2 Completed